Pulmonary involvements of anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis in Japan

Nephrology Dialysis Transplantation

Volumn 30, Issue , 2015, Pages i83-i93

  Hirayama, Kouichi ^a   Kobayashi, Masaki ^a   Usui, Joichi ^b   Arimura, Yoshihiro ^c   Sugiyama, Hitoshi ^d   Nitta, Kosaku ^e   Muso, Eri ^f   Wada, Takashi ^g   Matsuo, Seiichi ^h   Yamagata, Kunihiro ^b  

^a Tokyo Medical University Ibaraki Medical Center   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

^e TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^f Kitano Hospital   (Japan)

^g KANAZAWA UNIVERSITY   (Japan)

^h NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

alveolar hemorrhage; ANCA associated vasculitis; interstitial lung disease; mortality

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE;

ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; ASTHMA; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FIBROSING ALVEOLITIS; HUMAN; INTERSTITIAL LUNG DISEASE; JAPAN; LUNG DISEASE; LUNG GRANULOMA; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PLASMAPHERESIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; THORAX RADIOGRAPHY; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; COMPARATIVE STUDY; COMPLICATION; EUROPE; GLOMERULONEPHRITIS; HEMORRHAGE; LUNG DISEASES; MIDDLE AGED;

AGED; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; EUROPE; FEMALE; GLOMERULONEPHRITIS; HEMORRHAGE; HUMANS; JAPAN; LUNG DISEASES; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84926680392     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu385     Document Type: Article

References (52)

1. Lane SE, Watts RA, Shepstone L et al. Primary systemic vasculitis: clinical features and mortality. Q J Med 2005; 98: 97-111
2. Manganelli P, Fietta P, Carotti M et al. Respiratory system involvement in systemic vasculitides. Clin Exp Rheumatol 2006; 24: S48-S59
3. Thickett DR, Richter AG, Nathani N et al. Pulmonary manifestations of antineutrophil cytoplasmic antibody (ANCA)-positive vasculitis. Rheumatology 2006; 45: 261-268
4. West S, Arulkumaran N, Ind PW et al. Diffuse alveolar haemorrhage in ANCA-associated vasculitis. Intern Med 2013; 52: 5-13
5. Watts RA, Scott DG, Jayne DR et al. Renal vasculitis in Japan and the UK-are there differences in epidemiology and clinical phenotype? Nephrol Dial Transplant 2008; 23: 3928-3931
6. Hervier B, Pagnoux C, Agard C et al. Pulmonary fibrosis associated with ANCA-positive vasculitides. Retrospective study of 12 cases and review of the literature. Ann Rheum Dis 2009; 68: 404-407
7. Arulkumaran N, Periselneris N, Gaskin G et al. Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study. Rheumatology 2011; 50: 2035-2043
8. Uezono S, Sato Y, Hara S et al. Outcome of ANCA-associated primary renal vasculitis in Miyazaki Prefecture. Intern Med 2007; 46: 815-822
9. Sada KE, Yamamura M, Harigai M et al. Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study. Arthritis Res Ther 2014; 16: R101
10. Homma S, Matsushita H, Nakata K. Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitides. Respir-ology 2004; 9: 190-196
11. Furuta S, Chaudhry AN, Hamano Y et al. Comparison of phenotype and outcome in microscopic polyangiitis between Europe and Japan. J Rheumatol 2014; 41: 325-333
12. Yamagata K, Usui J, Saito C et al. ANCA-associated systemic vasculitis in Japan: clinical features and prognostic changes. Clin Exp Nephrol 2012; 16: 580-588
13. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-192
14. Haworth SJ, Savage CO, Carr D et al. Pulmonary haemorrhage complicating Wegener's granulomatosis and microscopic polyarteritis. Br Med J 1985; 290: 1775-1778
15. Hogan SL, Nachman PH, Wilkman AS et al. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996; 7:23-32
16. Gallagher H, Kwan JT, Jayne DR. Pulmonary renal syndrome: a 4-year, single-center experience. Am J Kidney Dis 2002; 39: 42-47
17. Lauque D, Cadranel J, Lazor R et al. Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Groupe d'Etudes et de Recherche sur les Maladies 'Orphelines' Pulmonaires (GERM'O'P). Medicine 2000; 79: 222-233
18. Kostianovsky A, Hauser T, Pagnoux C et al. Alveolar haemorrhage in ANCA-associated vasculitides: 80 patients' features and prognostic factors. Clin Exp Rheumatol 2012; 30: S77-S82
19. Hruskova Z, Casian AL, Konopasek P et al. Long-term outcome of severe alveolar haemorrhage in ANCA-associated vasculitis: a retrospective cohort study. Scand J Rheumatol 2013; 42: 211-214
20. Nada AK, Torres VE, Ryu JH et al. Pulmonary fibrosis as an unusual clinical manifestation of a pulmonary-renal vasculitis in elderly patients. Mayo Clin Proc 1990; 65: 847-856
21. Gal AA, Salinas FF, Staton GW, Jr. The clinical and pathological spectrum of antineutrophil cytoplasmic autoantibody-related pulmonary disease. A comparison between perinuclear and cytoplasmic antineutrophil cytoplasmic autoantibodies. Arch Pathol Lab Med 1994; 118: 1209-1214
22. Gaudin PB, Askin FB, Falk RJ et al. The pathologic spectrum of pulmonary lesions in patients with antineutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase. Am J Clin Pathol 1995; 104: 7-16
23. Akikusa B, Kondo Y, Irabu N et al. Six cases of microscopic polyarteritis exhibiting acute interstitial pneumonia. Pathol Int 1995; 45: 580-588
24. Becker-Merok A, Nossent JC, Ritland N. Fibrosing alveolitis predating microscopic polyangiitis. Scand J Rheumatol 1999; 28: 254-256
25. Guillevin L, Durand-Gasselin B, Cevallos R et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999; 42:421-430
26. Hiromura K, Nojima Y, Kitahara T et al. Four cases of anti-myeloperoxidase antibody-related rapidly progressive glomerulonephritis during the course of idiopathic pulmonary fibrosis. Clin Nephrol 2000; 53: 384-389
27. Mansi IA, Opran A, Sondhi D et al. Microscopic polyangiitis presenting as idiopathic pulmonary fibrosis: is anti-neutrophilic cytoplasmic antibody testing indicated? Am J Med Sci 2001; 321: 201-202
28. Souid M, Terki NH, Nochy D et al. Myeloperoxidase antineutrophil cytoplasmic autoantibodies (MPO-ANCA)-related rapidly progressive glomerulonephritis (RPGN) and pulmonary fibrosis (PF) with dissociated evolution. Clin Nephrol 2001; 55: 337-338
29. Eschun GM, Mink SN, Sharma S. Pulmonary interstitial fibrosis as a presenting manifestation in perinuclear antineutrophilic cytoplasmic antibody microscopic polyangiitis. Chest 2003; 123:297-301
30. Tzelepis GE, Kokosi M, Tzioufas A et al. Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis. Eur Respir J 2010; 36: 116-121
31. Ahn JK, Hwang JW, Lee J et al. Clinical features and outcome of microscopic polyangiitis under a new consensus algorithm of ANCA-associated vasculitides in Korea. Rheumatol Int 2012; 32: 2979-2986
32. Huang H, Wang YX, Jiang CG et al. A retrospective study of microscopic polyangiitis patients presenting with pulmonary fibrosis in China. BMC Pulm Med 2014; 14: 8
33. Foulon G, Delaval P, Valeyre D et al. ANCA-associated lung fibrosis: analysis of 17 patients. Respir Med 2008; 102: 1392-1398
34. Nozu T, Kondo M, Suzuki K et al. A comparison of the clinical features of ANCA-positive and ANCA-negative idiopathic pulmonary fibrosis patients. Respiration 2009; 77: 407-415
35. Bhanji A, Karim M. Pulmonary fibrosis-an uncommon manifestation of anti-myeloperoxidase-positive systemic vasculitis? NDT Plus 2010; 3: 351-353
36. Tanaka T, Otani K, Egashira R et al. Interstitial pneumonia associated with MPO-ANCA: clinicopathological features of nine patients. Respir Med 2012; 106: 1765-1770
37. Eleftheriou D, Katsenos S, Zorbas S et al. Pulmonary fibrosis presenting as an early manifestation of microscopic polyangiitis. Monaldi Arch Chest Dis 2012; 77: 141-144
38. Ando M, Miyazaki E, Ishii T et al. Incidence of myeloperoxidase antineutrophil cytoplasmic antibody positivity and microscopic polyangitis in the course of idiopathic pulmonary fibrosis. Respir Med 2013; 107: 608-615
39. Raghu G, Collard HR, Egan JJ et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788-824
40. Gindre D, Peyrol S, Raccurt M et al. Fibrosing vasculitis in Wegener's granulomatosis: ultrastructural and immunohistochemical analysis of the vascular lesions. Virchows Arch 1995; 427: 385-393
41. Schnabel A, Reuter M, Csernok E et al. Subclinical alveolar bleeding in pulmonary vasculitides: correlation with indices of disease activity. Eur Respir J1999; 14: 118-124
42. Al Riyami BM, Al Kaabi JK, Elagib EM et al. Subclinical pulmonary haemorrhage causing a restrictive lung defect in three siblings with a unique urticarial vasculitis syndrome. Clin Rheumatol 2003; 22: 309-313
43. Birnbaum J, Danoff S, Askin FB et al. Microscopic polyangiitis presenting as a 'pulmonary-muscle' syndrome: is subclinical alveolar hemorrhage the mechanism of pulmonary fibrosis? Arthritis Rheum 2007; 56: 2065-2071
44. Foucher P, Heeringa P, Petersen AH et al. Antimyeloperoxidase-associated lung disease. An experimental model. Am J Respir Crit Care Med 1999; 160: 987-994
45. Cambridge G, Williams M, Leaker B et al. Anti-myeloperoxidase antibodies in patients with rheumatoid arthritis: prevalence, clinical correlates, and IgG subclass. Ann Rheum Dis 1994; 53: 24-29
46. Little MA, Smyth L, Salama AD et al. Experimental autoimmune vasculitis: an animal model of anti-neutrophil cytoplasmic autoantibody-associated systemic vasculitis. Am J Pathol 2009; 174: 1212-1220
47. Sada KE, Amano K, Uehara R et al. A nationwide survey on the epidemiology and clinical features of eosinophilic granulomatosis with polyangiitis (Churg-Strauss) in Japan. Mod Rheumatol 2014; 24: 640-644
48. Comarmond C, Pagnoux C, Khellaf M et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term follow up of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum 2013; 65: 270-281
49. Watts R, Lane S, Hanslik T et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculit-ides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 2007; 66: 222-227
50. Booth AD, Almond MK, Burns A et al. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 2003; 41: 776-784
51. Weidner S, Geuss S, Hafezi-Rachti S et al. ANCA-associated vasculitis with renal involvement: an outcome analysis. Nephrol Dial Transplant 2004; 19: 1403-1411
52. Ozaki S, Atsumi T, Hayashi T et al. Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study. Mod Rheumatol 2012; 22: 394-404